Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 3Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 967Precursor Cell Lymphoblastic Leukemia-Lymphoma 585Leukemia, Lymphocytic, Chronic, B-Cell 555Leukemia 486Myelodysplastic Syndromes 375Lymphoma, Non-Hodgkin 347Lymphoma 297Lymphoma, Mantle-Cell 263Hematologic Neoplasms 260Lymphoma, Follicular 256Lymphoma, Large B-Cell, Diffuse 253Burkitt Lymphoma 232Lymphoma, B-Cell, Marginal Zone 227Recurrence 216Hodgkin Disease 182Multiple Myeloma 172Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159Lymphoma, Large-Cell, Immunoblastic 158Leukemia, Myelomonocytic, Chronic 153Leukemia, Myelogenous, Chronic, BCR-ABL Positive 147Waldenstrom Macroglobulinemia 123Lymphoma, T-Cell, Cutaneous 116Neoplasms 112Lymphoma, Large-Cell, Anaplastic 111Blast Crisis 105Congenital Abnormalities 104Immunoblastic Lymphadenopathy 98Mycosis Fungoides 97Sezary Syndrome 96Myeloproliferative Disorders 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bone Marrow Neoplasms × Other hematologic neoplasm × Clear all
NCT04709458 2022-05-03

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Taiga Biotechnologies, Inc.

Phase 1 Unknown
10 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡